Theranib Inc. has divulged retinal dehydrogenase 1 (ALDH1A1; RALDH1) and/or retinal dehydrogenase 2 (ALDH1A2; RALDH2) and/or aldehyde dehydrogenase family 1 member A3 (ALDH1A3; RALDH3) inhibitors ...

Oral squamous cell carcinoma (OSCC) remains one of the most prevalent and aggressive forms of oral cancer, with a notoriously poor prognosis. While risk factors like tobacco use and alcohol ...